✦ LIBER ✦

531 High Dose Combination Therapy (Peginterferon Alfa-2a Plus Ribavirin) in Difficult-to-Cure Patients With Chronic Hepatitis C: Impact on Rvr, Cevr and SVR

✍ Scribed by Reddy, Rajender; Shiffman, Mitchell L.; Rodriguez-Torres, Maribel; Abdurakhmanov, Djamal; Bakulin, Igor G.; Silva, Giovanni Faria; Cheinquer, Hugo; Rabbia, Michael A.; Mckenna, Michael; Tietz, Andreas; Harrison, Stephen A.

Book ID: 122026278
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 130 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63634-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Asian Race on Response to Comb

Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C

✍ Missiha, Sharif; Heathcote, Jenny; Arenovich, Tamara; Khan, Kamran 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

292 IMPACT OF HIGHER DOSES OF PEGINTERFE

292 IMPACT OF HIGHER DOSES OF PEGINTERFERON ALFA-2A AND RIBAVIRIN ON RVR, CEVR AND SVR IN HCV G1 PATIENTS WITH VIRAL LOADS ≥400,000 IU/ML WEIGHING ≥85 kg

✍ K.R. Reddy; M.L. Shiffman; M. Rodriguez-Torres; D. Abdurakhmanov; I. Bakulin; G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

522 Combination therapy with peginterfer

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Dose Reduction of Peginterferon Alfa-2a

Dose Reduction of Peginterferon Alfa-2a (PEG) in Combination With Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients: Impact on Virological Response Under Real Life Conditions

✍ Boeker, Klaus ;Mauss, Stefan ;Hueppe, Dietrich ;Schuchmann, Marcus ;Schiffelholz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

505 The influence of cumulative exposure

505 The influence of cumulative exposure to combination peginterferon alfa-2A (40 KD) (Pegasys) and ribavirin on sustained virological response (SVR) rates in patients with genotype 1 chronic hepatitis C

✍ K.R. Reddy; M.W. Fried; M.L. Shiffman; S.J. Hadziyannis; H. Sette; T.R. Morgan; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

404 DOSE REDUCTION OF PEGINTERFERON ALFA

404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS

✍ K. Boeker; S. Mauss; D. Hueppe; M. Schuchmann; W. Schiffelholz; A. Baumgarten; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB